114 related articles for article (PubMed ID: 14999095)
1. Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
Calmels C; de Soultrait VR; Caumont A; Desjobert C; Faure A; Fournier M; Tarrago-Litvak L; Parissi V
Nucleic Acids Res; 2004; 32(4):1527-38. PubMed ID: 14999095
[TBL] [Abstract][Full Text] [Related]
2. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
3. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the DNA substrate structure and number of the processing sites on the activities of HIV-1 integrase in vitro.
Sayasith K; Sauvé G; Yelle J
Mol Cells; 2001 Apr; 11(2):231-40. PubMed ID: 11355706
[TBL] [Abstract][Full Text] [Related]
5. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mutant HIV-1 integrase carrying amino acid changes in the catalytic domain.
Sayasith K; Sauvé G; Yelle J
Mol Cells; 2000 Oct; 10(5):525-32. PubMed ID: 11101143
[TBL] [Abstract][Full Text] [Related]
7. Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. integrase inhibition.
Lee-Huang S; Huang PL; Zhang D; Lee JW; Bao J; Sun Y; Chang YT; Zhang J; Huang PL
Biochem Biophys Res Commun; 2007 Mar; 354(4):879-84. PubMed ID: 17261269
[TBL] [Abstract][Full Text] [Related]
8. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
Yang ZN; Mueser TC; Bushman FD; Hyde CC
J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607
[TBL] [Abstract][Full Text] [Related]
10. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
Konsavage WM; Sudol M; Katzman M
Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
[TBL] [Abstract][Full Text] [Related]
11. [HIV-1 integrase inhibition by dimeric bisbenzimidazoles having different spacers].
Korolev SP; Tashlitskiĭ VN; Smolov MA; Gromyko AV; Zhuze AL; Agapkina IuIu; Gottikh MB
Mol Biol (Mosk); 2010; 44(4):718-27. PubMed ID: 20873232
[TBL] [Abstract][Full Text] [Related]
12. Mutational scan of the human immunodeficiency virus type 2 integrase protein.
van den Ent FM; Vos A; Plasterk RH
J Virol; 1998 May; 72(5):3916-24. PubMed ID: 9557677
[TBL] [Abstract][Full Text] [Related]
13. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
14. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
15. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication.
Xu Z; Zheng Y; Ao Z; Clement M; Mouland AJ; Kalpana GV; Belhumeur P; Cohen EA; Yao X
Retrovirology; 2008 Nov; 5():102. PubMed ID: 19014595
[TBL] [Abstract][Full Text] [Related]
17. HIV integrase as a target for antiviral chemotherapy.
Nair V
Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
[TBL] [Abstract][Full Text] [Related]
18. Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro.
Moreau K; Faure C; Verdier G; Ronfort C
Arch Virol; 2002 Sep; 147(9):1761-78. PubMed ID: 12209315
[TBL] [Abstract][Full Text] [Related]
19. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51.
Desfarges S; San Filippo J; Fournier M; Calmels C; Caumont-Sarcos A; Litvak S; Sung P; Parissi V
Nucleic Acids Res; 2006; 34(21):6215-24. PubMed ID: 17090598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
